Cell biological study on abnormal proteoglycan synthesis in vascular cells exposed to heavy metals

Journal of Health Science

Volumn 50, Issue 3, 2004, Pages 197-204

  Fujiwara, Yasuyuki ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

Atherosclerosis; Cadmium; Lead; Proteoglycan; Vascular endothelial cell; Vascular smooth muscle cell

Indexed keywords

BIGLYCAN; CADMIUM; DECORIN; FIBROBLAST GROWTH FACTOR; HEAVY METAL; HEPARAN SULFATE; LEAD; PERLECAN; PROTEOGLYCAN;

ATHEROGENESIS; ATHEROSCLEROSIS; BLOOD VESSEL WALL; CELL CULTURE; CELL DENSITY; CELL PROLIFERATION; CYTOLOGY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; PROTEOGLYCAN SYNTHESIS; RISK FACTOR; SHORT SURVEY; SMOOTH MUSCLE FIBER; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 20444442196     PISSN: 13449702     EISSN: None     Source Type: Journal    
DOI: 10.1248/jhs.50.197     Document Type: Short Survey

References (55)

1. Ross, R. (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (London), 362, 801-809.
2. Sato, Y. and Rifkin, D. B. (1988) Autocrine activities of bovine basic fibroblast growth factor: regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J. Cell Biol., 107, 1199-1205.
3. Yayon, A., Klagsbrun, M., Esko, J. D., Leder, P. and Ornitz, D. M. (1991) Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell, 64, 841-848.
4. Ornitz, D. M., Yayon, A., Flanagan, J. G., Svahn, C. M., Levi, E. and Leder, P. (1992) Heparin is required for cell-free binding of basic fibroblast growth factor to a soluble receptor and for mitogenesis in whole cells. Mol. Cell. Biol., 12, 240-247.
5. Rusnati, M. and Presta, M. (1996) Interaction of angiogenic basic fibroblast growth factor with endothelial cell heparan sulfate proteoglycans. Biological implications in neovascularization. Int. J. Clin. Lab. Res., 26, 15-23.
6. Ruoslahti, E. (1988) Structure and biology of proteoglycans. Annu. Rev. Cell Biol., 4, 229-255.
7. Wight, T. N. (1980) Vessel proteoglycans and thrombogenesis. Prog. Hemost. Thromb., 5, 1-39.
8. Iozzo, R. V., Cohen, I. R., Grassel, S. and Murdoch, A. D. (1994) The biology of perlecan: the multifaceted heparan sulfate proteoglycan of basement membranes and pericellular matrices. Biochem. J., 302, 625-639.
9. Mertens, G., Cassiman, J. J., van den Berghe, H., Vermylen, J. and David, G. (1992) Cell surface heparan sulfate proteoglycans from human vascular endothelial cells: core protein characterization and antithrombin III binding properties. J. Biol. Chem., 267, 20435-20443.
10. Saku, T. and Furthmayr, H. (1989) Characterization of the major heparan sulfate proteoglycan secreted by bovine aortic endothelial cells in culture. Homology to the large molecular weight molecule of basement membranes. J. Biol. Chem., 264, 3514-3523.
11. Aviezer, D., Hecht, D., Safran, M., Eisinger, M., David, G. and Yayon, A. (1994) Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis and angiogenesis. Cell, 79, 1005-1013.
12. Aviezer, D., Levy, E., Safran, M., Svahn, C., Buddecke, E., Schmidt, A., David, G., Vlodavsky, I. and Yayon, A. (1994) Differential structural requirements of heparin and heparan sulfate proteoglycans that promote binding of basic fibroblast growth factor to its receptor. J. Biol. Chem., 269, 117-121.
13. Morita, H., Takeuchi, T., Suzuki, S., Maeda, K., Yamada, K., Eguchi, G. and Kimata, K. (1990) Aortic endothelial cells synthesized a large chondroitin sulfate proteoglycan capable of binding to hyaluronate. Biochem. J., 265, 61-68.
14. Järveläinen, H. T., Kinsella, M. G., Wight, T. N. and Sandell, L. J. (1991) Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture. J. Biol. Chem., 266, 23274-23281.
15. Schönherr, E., Järveläinen, H. T., Sandell, L. J. and Wight, T. N. (1991) Effects of platelet-derived growth factor and transforming growth factor-beta 1 on the synthesis of a large versican-like chondroitin sulfate proteoglycan by arterial smooth muscle cells. J. Biol. Chem., 266, 17640-17647.
16. Yao, L. Y., Moody, C., Schönherr, E., Wight, T. N. and Sandell, L. J. (1994) Identification of the proteoglycan versican in aorta and smooth muscle cells by DNA sequence analysis, in situ hybridization and immunohistochemistry. Matrix Biol., 14, 213-225.
17. Schönherr, E., Järveläinen, H. T., Kinsella, M. G., Sandell, L. J. and Wight, T. N. (1993) Platelet-derived growth factor and transforming growth factor-β1 differentially affect the synthesis of biglycan and decorin by monkey arterial smooth muscle cells. Arterioscler. Thromb., 12, 1026-1036.
18. Dingwall-Fordyce, I. and Lane, R. E. (1963) A follow-up study of lead workers. Br. J. Ind. Med., 20, 313-315.
19. Revis, N. W., Major, T. C. and Horton, C. Y. (1980) The effects of calcium, magnesium, lead, or cadmium on lipoprotein metabolism and atherosclerosis in the pigeon. J. Environ. Pathol. Toxicol., 4, 293-303.
20. Revis, N. W., Zinsmeister, A. R. and Bull, R. (1981) Atherosclerosis and hypertension induced by lead and cadmium ions: an effect prevented by calcium ion. Proc. Natl. Acad. Sci. U.S.A., 78, 6494-6498.
21. Pirkle, J. L., Schwartz, J., Landis, J. R. and Harlan, W. R. (1985) The relationship between blood lead levels and blood pressure and its cardiovascular risk implications. Am. J. Epidemiol., 121, 246-258.
22. Tomera, J. F. and Harakal, C. (1986) Mercury- and lead-induced contraction of aortic smooth muscle in vitro. Arch. Int. Pharmacodyn. Ther., 283, 295-302.
23. Perry, H. M., Jr., Erlanger, M. W. and Perry, E. F. (1988) Increase in the blood pressure of rats chronically fed low levels of lead. Environ. Health Perspect., 78, 107-111.
24. Lal, B., Murthy, R. C., Anand, M., Chandra, S. V., Kumar, R., Tripathi, O. and Srimal, R. C. (1991) Cardiotoxicity and hypertension in rats after oral lead exposure. Drug Chem. Toxicol., 14, 305-318.
25. Schwartz, J. (1991) Lead, blood pressure, and cardiovascular disease in men and women. Environ. Health Perspect., 91, 71-75.
26. Watts, S. W., Chai, S. and Webb, R. C. (1995) Lead acetate-induced contraction in rabbit mesenteric artery: interaction with calcium and protein kinase C. Toxicology, 99, 55-65.
27. Houtman, J. P. (1996) Trace elements and cardiovascular diseases. J. Cardiovasc. Risk, 3, 18-25.
28. Houston, D. K. and Johnson, M. A. (1999) Lead as a risk factor for hypertension in women. Nutr. Rev., 57, 277-279.
29. Perry, H. M., Jr. and Schroeder, H. A. (1955) Concentration of trace metals in urine of treated and untreated hypertensive patients compared with normal subjects. J. Lab. Clin. Med., 46, 936.
30. Schroeder, H. A. and Vinton, W. H., Jr. (1962) Hypertension induced in rats by small doses of cadmium. Am. J. Physiol. 202, 515-518.
31. Glauser, S. C., Bello, C. T. and Glauser, E. M. (1976) Blood-cadmium levels in normotensive and untreated hypertensive humans. Lancet, 1, 717-718.
32. Revis, N. (1978) A possible mechanism for cadmium-induced hypertension in rats. Life Sci., 22, 479-487.
33. Perry, H. M., Erlanger M. and Perry, E. F. (1979) Increase in the systolic pressure of rats chronically fed cadmium. Environ. Health Perspect., 28, 251-260.
34. Niwa, A. and Suzuki, A. (1982) Effects of cadmium on the tension of isolated rat aorta (a possible mechanism for cadmium-induced hypertension). J. Toxicol. Sci., 7, 51-60.
35. Perry, H. M., Jr., Erlanger, M. W. and Perry, E. F. (1983) Effect of a second metal on cadmium-induced hypertension. Arch. Environ. Health, 38, 80-85.
36. Aalbers, T. G. and Houtman, J. P. (1985) Relationships between trace elements and atherosclerosis. Sci. Total Environ., 43, 255-283.
37. Evans, D. H. and Weingarten, K. (1990) The effect of cadmium and other metals on vascular smooth muscle of the dogfish shark, Squalus acanthias. Toxicology, 61, 275-281.
38. Subramanyam, G., Bhaskar, M. and Govindappa, S. (1992) The role of cadmium induction of atherosclerosis in rabbits. Indian Heart J., 44, 177-180.
39. Houtman, J. P. (1993) Prolonged low-level cadmium intake and atherosclerosis. Sci. Total Environ., 138, 31-36.
40. Kaji, T. (2004) Cell biology of heavy metal toxicity in vascular tissue. Yakugaku Zasshi, 124, 113-120.
41. Yamamoto, C. (2000) Toxicity of cadmium and lead on vascular cells that regulate fibrinolysis. Yakugaku Zasshi, 120, 463-473.
42. Fujiwara, Y. and Kaji, T. (2000) Inhibition of the repair of injured endothelial cell monolayers by lead and its possible mechanisms. J. Health Sci., 46, 1-4.
43. Kaji, T., Suzuki, M., Yamamoto, C., Mishima, A., Sakamoto, M. and Kozuka, H. (1995) Severe damage of cultured vascular endothelial cell monolayer after simultaneous exposure to cadmium and lead. Arch. Environ. Contam. Toxicol., 28, 168-172.
44. Fujiwara, Y., Kaji, T., Sakurai, S., Sakamoto, M. and Kozuka, H. (1997) Inhibitory effect of lead on the repair of wounded monolayers of cultured vascular endothelial cells. Toxicology, 117, 193-198.
45. Kaji, T., Fujiwara, Y., Hoshino, M., Yamamoto, C., Sakamoto, M. and Kozuka, H. (1995) Inhibitory effect of lead on the proliferation of cultured vascular endothelial cells. Toxicology, 95, 87-92.
46. Fujiwara, Y. and Kaji, T. (1999) Possible mechanism for lead inhibition of vascular endothelial cell proliferation: a lower response to basic fibroblast growth factor through inhibition of heparan sulfate synthesis. Toxicology, 133, 147-157.
47. Fujiwara, Y. and Kaji, T. (1999) Lead inhibits the core protein synthesis of a large heparan sulfate proteoglycan perlecan by proliferating vascular endothelial cells in culture. Toxicology, 133, 159-169.
48. Gutierrez, P., O'Brien, K. D., Ferguson, M., Nikkari, S. T., Alpers, C. E. and Wight, T. N. (1997) Differences in the distribution of versican, decorin, and biglycan in atherosclerotic human coronary arteries. Cardiovasc. Pathol., 6, 271-278.
49. Shirk, R. A., Parthasarathy, N., San Antonio, J. D., Church, F. C. and Wagner, W. D. (2000) Altered dermatan sulfate structure and reduced heparin cofactor II-stimulating activity of biglycan and decorin from human atherosclerotic plaque. J. Biol. Chem., 275, 18085-18092.
50. Camejo, G., Acquatella, H. and Lalaguna, F. (1980) The interaction of low density lipoproteins with arterial proteoglycans. An additional risk factor? Atherosclerosis, 36, 55-65.
51. Salisbury, B. G., Falcone, D. J. and Minick, C. R. (1985) Insoluble low-density lipoprotein-proteoglycan complexes enhance cholesteryl ester accumulation in macrophages. Am. J. Pathol., 120, 6-11.
52. Williams, K. J. and Tabas, I. (1995) The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol., 15, 551-561.
53. Fujiwara, Y., Yamamoto, C. and Kaji, T. (2000) Proteoglycans synthesized by cultured bovine aortic smooth muscle cells after exposure to lead: lead selectively inhibits the synthesis of versican, a large chondroitin sulfate proteoglycan. Toxicology, 154, 9-19.
54. Fujiwara, Y., Yamamoto, C., Kaji, T. and Plaas, A. H. (2003) Analysis of chondroitin/dermatan sulfate microstructure in cultured vascular smooth muscle cells after exposure to lead and cadmium. J. Health Sci., 49, 534-540.
55. Fujiwara, Y., Tsumura, N., Yamamoto, C. and Kaji, T. (2002) Different effects of cadmium on proteoglycan synthesis of arterial smooth muscle cells: increase in small dermatan sulfate proteoglycans, biglycan and decorin, in the extra-cellular matrix at low cell density. Toxicology, 170, 89-101.